EyePoint Pharmaceuticals Announces Stockholder Approval of Second Tranche of Capital Financing

Go back to EyePoint Pharmaceuticals Announces Stockholder Approval of Second Tranche of Capital Financing
(NASDAQ: EYPT) Delayed: 4.22 -0.03 (0.71%)
Previous Close $4.25    52 Week High
Open $4.32    52 Week Low
Day High $4.43    P/E N/A 
Day Low $4.20    EPS
Volume 1,071,187